Boston Scientific Corp

Connor, Clark & Lunn Investment Management Ltd. BSX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

818,916

Value ($000)

78,084

Weight

0.2%

2014 Q1 - 2025 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	78,084	0.2%	818,916	12/31/2025
2025 Q3	11/13/2025	25,281	0.1%	258,947	9/30/2025
2025 Q2	8/7/2025	230	0.0%	2,145	6/30/2025
2025 Q1	5/12/2025	10,903	0.0%	108,080	3/31/2025
2024 Q4	2/10/2025	7,288	0.0%	81,591	12/31/2024
2024 Q3	11/8/2024	18,332	0.1%	218,756	9/30/2024
2024 Q2	8/9/2024	1,794	0.0%	23,295	6/30/2024
2024 Q1	5/9/2024	797	0.0%	11,631	3/31/2024
2023 Q4	2/9/2024	4,909	0.0%	84,912	12/31/2023
2022 Q3	11/10/2022	6,393	0.0%	165,073	9/30/2022
2022 Q2	8/5/2022	6,256	0.0%	167,844	6/30/2022
2022 Q1	5/12/2022	13,024	0.1%	294,051	3/31/2022
2021 Q2	8/12/2021	4,052	0.0%	94,751	6/30/2021
2021 Q1	5/13/2021	8,785	0.0%	227,304	3/31/2021
2020 Q3	11/12/2020	7,266	0.0%	190,152	9/30/2020
2019 Q4	2/12/2020	1,506	0.0%	33,313	12/31/2019
2014 Q1	5/14/2014	2,254	0.0%	151,066	3/31/2014